Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Oct 13, 2026Periodic report · 6-KFiled by the company itself.Open the filing ↗
- Sep 30, 2026Periodic report · 6-KFiled by the company itself.Open the filing ↗
- Aug 11, 2026Notice of sale · Form 144mDR Ltd · 10% Stockholder · $103.3KOpen the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record1157 flagged findings
Reported transactions (Form 4)3since May 13, 2026 · and 13 other holdings
Corporate events (8-K)0
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
The 25 most recent filings (of 115)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Oct 16, 26SCHEDULE 13D/A ↗Stake with intent to influence · Choo Chee Kong · 25.2% · event on Oct 12, 26 · amendment new
- Oct 13, 26SCHEDULE 13D/A ↗Stake with intent to influence · Choo Chee Kong · 24.9% · event on Oct 6, 26 · amendment new
- Oct 13, 266-K ↗Foreign issuer report new
- Sep 30, 266-K ↗Foreign issuer report
- Aug 11, 26Form 144 ↗Notice of proposed sale
- Jul 24, 26Form 4/A ↗Insider transaction · amendment
- Jul 24, 26SCHEDULE 13D/A ↗Stake with intent to influence · Choo Chee Kong · 24.3% · event on Jul 20, 26 · amendment
- Jul 24, 26Form 4 ↗Insider transaction
- Jun 23, 266-K ↗Foreign issuer report
- Jun 15, 26Form 4 ↗Insider transaction
- Jun 3, 266-K ↗Foreign issuer report
- May 15, 266-K ↗Foreign issuer report
- May 13, 26Form 144 ↗Notice of proposed sale
- May 11, 266-K ↗Foreign issuer report
- Apr 14, 266-K ↗Foreign issuer report
- Mar 31, 266-K ↗Foreign issuer report
- Mar 31, 2620-F ↗Annual report
- Feb 12, 26Form 144 ↗Notice of proposed sale
- Jan 28, 266-K ↗Foreign issuer report
115 filings on record, the oldest from Oct 26, 21.
Listing the 25 most recent filings of the 115 on record.
Schedule 13D: stake and stated purpose
Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.
- Choo Chee Kong25.2%Oct 12, 26SCHEDULE 13D/A ↗4 earlier filings
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- mDR LTD11.3%Dec 16, 24SCHEDULE 13G/A ↗
- 28 Consultants Ltd7.6%Feb 17, 25SCHEDULE 13G ↗
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
Sale intention announced
On Aug 11, mDR Ltd filed notice of intent to sell up to $103K. That is about 0.99% of shares outstanding.
A notice is not a sale: it may not go ahead, may happen in part, or at a different price.
No sale of theirs is on record yet in Form 4; the 90-day window is still open.
The full record holds 3 transactions and goes back to Mar 31, 23.
Its sector and its market
Cytomed Therapeutics Ltd. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Cytomed Therapeutics Ltd., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Cytomed Therapeutics Ltd. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- 250 clean closes in the period.
- SEC records
- 115 documents on file, from Oct 26, 2021 to Oct 16, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.